650 Fund I / Past investments *
650, a venture capital firm, was launched by Grace Stanat and Dominik Steiner as the natural evolution of a successful early-stage investment model first developed at 415 Investments. With over 40% IRR across 50+ investments, the team has always focused on identifying high-potential opportunities early and building deep trust with founders.Deploying over $25M across select opportunities, with notable exits including Lemonaid Health (acquired by 23andMe for $400M), Aumni (acquired by JPMorgan for $400M), and Nervana (acquired by Intel with a 41x return). Our consistent ability to back breakout companies has cemented 650’s reputation as early-stage experts.
Showcasing global investment success
Past Investments
Some companies that exceeded our LPs' expectations
Nervana
Nervana Systems, a deep learning startup acquired by Intel in 2016 for around $408 million, focused on developing AI software and hardware, including a full-stack software-as-a-service platform called Nervana Cloud and custom chips for neural network processing.
Lemonaid Health
Lemonaid Health is a telehealth company offering convenient, affordable and personalized healthcare services, including online medical consultations and prescriptions for various conditions, with a focus on mental health, general health, and other specific areas.
Rewrite
Rewrite Therapeutics was a biotechnology company focused on developing novel DNA writing technologies, particularly a CRISPR-based evolution platform, which was acquired by Intellia Therapeutics in February 2022.
Diamond Foundry
Diamond Foundry is a company that designs, develops, and builds a semiconductor-grade tech stack, focusing on creating single-crystal diamond wafers for applications like AI, electric vehicles, and wireless communication, aiming for a "real zero" carbon footprint.
* Fund I is used herein to refer to both 650 Fund I as a legal entity and past investments made by the Founding GPs outside of the Fund